Ionis Pharmaceuticals Inc (NASDAQ:IONS)

48.51
Delayed Data
As of Apr 20
 +2.66 / +5.80%
Today’s Change
40.33
Today|||52-Week Range
65.51
-3.56%
Year-to-Date

Today’s Trading

Previous close45.85
Today’s open50.44
Day’s range46.77 - 50.44
Volume4,732,524
Average volume (3 months)1,040,405
Market cap$6.6B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-685.42%
Earnings growth (next 5 years)+44.00%
Revenue growth (last year)+46.46%
P/E ratio606.4
Price/Sales12.49
Price/Book20.01

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc-0.63-1.21%
SGENSeattle Genetics Inc+0.11+0.22%
UTHRUnited Therapeutics ...+1.07+0.95%
ALKSAlkermes Plc-0.13-0.28%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)$0.02
Annual revenue (last year)$507.7M
Annual profit (last year)$9.7M
Net profit margin1.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Stanley T. Crooke
Chief Operating Officer
Brett P. Monia
Corporate headquarters
Carlsbad, California

Forecasts